| Name | Title | Contact Details |
|---|
Epic! was born out of a single question: How do we make books more accessible to kids? As parents, it always seemed strange to us that our kids could so easily play games and watch videos on their iPhones and iPads, but the same couldn`t be said for books. So in 2013, we decided to build the first `epic` reading experience, designed just for kids. Today, Epic! has grown into an award-winning subscription service, which gives millions of families and classrooms instant, unlimited access to thousands of books, videos and quizzes from leading publishers to help kids everywhere read, learn and grow.
PracticeBetter.io is a comprehensive practice management platform designed to help health and wellness professionals streamline their workflows and grow their businesses. Its intuitive interface allows practitioners to seamlessly manage schedules, appo...
MediMobile is Mobile Charge Capture software, the leading technology provider of practice and revenue cycle management in healthcare.
Juventas Therapeutics is a private clinical-stage company developing novel therapies for ischemic cardiovascular disease. The company`s lead product` JVS-100` is a non-viral plasmid that encodes for stromal cell-derived factor-1 (SDF-1). SDF-1 has been shown to significantly increase end-organ function following tissue injury by promoting cell survival` recruiting endogenous stem cells to the damaged region` and promoting new blood vessel growth. The SDF-1 repair pathway is well conserved throughout end-organ systems providing the opportunity to impact a broad range of diseases. Target cardiovascular clinical indications address large markets with high unmet medical need and significant market potential. Juventas is currently enrolling multiple clinical trials to test therapy efficacy in heart failure and critical limb ischemia patients.